Viskase Companies, Inc., together with its subsidiaries, produces and sells non-edible cellulosic, fibrous, and plastic casings for preparing and packaging processed meat products and services in North America, South America, Europe, Asia, and internationally. The company offers NOJAX cellulose casings for use in the automated production of hot dogs, dry mini salamis, and cooked and coarse ground sausages; and large cellulose casings to give cylindrical or oval shape to the processed meats that are used in bologna, mortadella, deli ham, bierwurst, and dry sausages. It also provides VISDRY casings for dried or smoked sausages; VISFLEX casings for cheese and processed meat applications; VISMAX casings for molded, and formed processed meat and poultry applications; VISLON for meat, poultry, and cheese applications; VISMOKE casings for cooked and smoked meat products, semi-dry sausages, and spreadable dry sausages; VISCOAT casings for a range of applications, including turkey, ham, and roast beef products; and POLYJAX casings for the production of hot dog, sausage, chorizo products, and meat snack sticks. In addition, the company provides fibrous casings for use in a range of applications, including pepperoni, salami, boneless hams, luncheon meats, and other deli-style processed meats, as well as for processed and smoked cheeses; color transfer casings for a range of natural and synthetic shades; flavor transfer casings for taste profiles; smoke transfer casings for processed meat or cheese products; and spice transfer casings for processing facility. Additionally, it offers textile spice transfer casings for transfer of the spice to the food; Ve-Net products; and MEMBRA-CEL, a dialysis membranes made from regenerated cellulose. The company was founded in 1925 and is based in Lombard, Illinois. Viskase Companies, Inc. is a subsidiary of Icahn Enterprises L.P.
The current price of ENZN is $4.35 USD — it has decreased by -0.84% in the past 24 hours. Watch Enzon Pharmaceuticals stock price performance more closely on the chart.
What is Enzon Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Enzon Pharmaceuticals stocks are traded under the ticker ENZN.
Is Enzon Pharmaceuticals stock price growing?▼
ENZN stock has risen by +0% compared to the previous week, the month change is a -12.83% fall, over the last year Enzon Pharmaceuticals has showed a -45.56% decrease.
What is Enzon Pharmaceuticals market cap?▼
Today Enzon Pharmaceuticals has the market capitalization of 62.34M
What were Enzon Pharmaceuticals earnings last quarter?▼
ENZN earnings for the last quarter are -0.01 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Enzon Pharmaceuticals revenue for the last year?▼
Enzon Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Enzon Pharmaceuticals net income for the last year?▼
ENZN net income for the last year is -5.53M USD.
Does Enzon Pharmaceuticals pay dividends?▼
Yes, ENZN dividends are paid annual. The last dividend per share was 12 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Enzon Pharmaceuticals have?▼
As of July 29, 2026, the company has 1,582 employees.
In which sector is Enzon Pharmaceuticals located?▼
Enzon Pharmaceuticals operates in the Health & Wellness sector.
When did Enzon Pharmaceuticals complete a stock split?▼
The last stock split for Enzon Pharmaceuticals was on March 25, 2026 with a ratio of 1:100.
Where is Enzon Pharmaceuticals headquartered?▼
Enzon Pharmaceuticals is headquartered in Lombard, United States.